Francisco Abad‐Santos

Author

Hospital Universitario de La Princesa ORCID

Also Known As

Abad-Santos, Francisco, Alejandro Calderon Jiménez, Carmen Belmonte, D. Ochoa, E. Daudén, F A Santos, F ABAD, F ABADSANTOS, F Abad, F Abad Santos

425

Publications

6.6K

Citations

H-Index

157

Concepts

All Affiliations

Hospital Universitario de La Princesa Universidad Autónoma de Madrid Instituto de Salud Carlos III Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas Spanish Clinical Research Network

About

Francisco Abad‐Santos is an author at Hospital Universitario de La Princesa specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	53	2.5K
2	Public Health	6	6	128
3	Social Sciences	3	3	111
4	Health Sciences	2	2	36
5	Natural Sciences	2	2	36

Francisco Abad‐Santos

121

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study Francisco J. de Abajo, Sara Rodríguez‐Martín, Victoria Lerma, The Lancet Case-population StudyHypertensionPreventive MedicineCardiovascular DiseaseAntihypertensive Therapy	2020	418
A Neutrophil Timer Coordinates Immune Defense and Vascular Protection José M. Adrover, Carlos del Fresno, Georgiana Crainiciuc, Immunity InflammationAutoimmune DiseaseVascular ProtectionGranulocyteInnate Immune System	2019	408
Effect of the Most Relevant CYP3A4 and CYP3A5 Polymorphisms on the Pharmacokinetic Parameters of 10 CYP3A Substrates Miriam Saiz‐Rodríguez, Susana Almenara, Marcos Navares‐Gómez, Biomedicines	2020	110
Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial H. C. Rümke, José-María Bayas, José-Ramón de Juanes, Vaccine VaccinationVaccine SafetyCross-protectionVaccine DevelopmentImmunology	2008	94
Influence of <i><scp>CYP</scp>2D6</i>,<i><scp>CYP</scp>3A4</i>,<i><scp>CYP</scp>3A5</i> and <i><scp>ABCB</scp>1</i> Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers Carmen Belmonte, Dolores Ochoa, Manuel Román, Basic & Clinical Pharmacology & Toxicology	2018	79
Histone modifications associated with biological drug response in moderate‐to‐severe psoriasis María C. Ovejero‐Benito, Alejandra Reolid, Patricia Sánchez‐Jiménez, Experimental Dermatology	2018	74
The relationship between tumour necrosis factor (TNF)-α promoter and<i>IL12B</i>/<i>IL-23R</i>genes polymorphisms and the efficacy of anti-TNF-α therapy in psoriasis: a case-control study Enrique Vázquez Gallo, Teresa Cabaleiro, Manuel Román, British Journal of Dermatology	2013	73
Effects of CYP2D6 Genotype on the Pharmacokinetics, Pharmacodynamics, and Safety of Risperidone in Healthy Volunteers Jesús Novalbos, Rosario López‐Rodríguez, Manuel Román, Journal of Clinical Psychopharmacology Cyp2d6 GenotypesCyp2d6 GenotypeHealthy VolunteersPharmacoepidemiologyPharmacology	2010	68
Effect of Polymorphisms on the Pharmacokinetics, Pharmacodynamics and Safety of Sertraline in Healthy Volunteers Miriam Saiz‐Rodríguez, Carmen Belmonte, Manuel Román, Basic & Clinical Pharmacology & Toxicology	2017	66
Influence of CYP2C8 and CYP2C9 polymorphisms on pharmacokinetic and pharmacodynamic parameters of racemic and enantiomeric forms of ibuprofen in healthy volunteers Rosario López‐Rodríguez, Jesús Novalbos, Sonia Gallego‐Sandín, Pharmacological Research Molecular PharmacologyPharmacological StudyHealthy VolunteersPharmacologyPharmacodynamic Parameters	2008	63

Page 1